CENCORA, INC. Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss
CENCORA, INC. (COR) reported Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss of $0 for the 12-month period ending 2020-09-30, per its 10-K filed 2020-11-19.
Discontinued › Expense Statement › Operating Expenses
us-gaap:BusinessCombinationStepAcquisitionEquityInterestInAcquireeRemeasurementLoss · last filed 2020-11-19
- CENCORA, INC. business combination, step acquisition, equity interest in acquiree, remeasurement loss for the quarter ending 2019-09-30 was $0.00.
- CENCORA, INC. business combination, step acquisition, equity interest in acquiree, remeasurement loss for the quarter ending 2019-06-30 was $0.00.
- CENCORA, INC. business combination, step acquisition, equity interest in acquiree, remeasurement loss for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- CENCORA, INC. business combination, step acquisition, equity interest in acquiree, remeasurement loss for the quarter ending 2018-09-30 was $0.00.
- CENCORA, INC. business combination, step acquisition, equity interest in acquiree, remeasurement loss for fiscal 2020 was $0.00.
- CENCORA, INC. business combination, step acquisition, equity interest in acquiree, remeasurement loss for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- CENCORA, INC. business combination, step acquisition, equity interest in acquiree, remeasurement loss for fiscal 2018 was $42.33M.
- CENCORA, INC. business combination, step acquisition, equity interest in acquiree, remeasurement loss for fiscal 2017 was $0.00.
| Period end | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss 3 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss 3 month as first filed | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss 6 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss 9 month | Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Loss 12 month |
|---|---|---|---|---|---|
| 2020-09-30 | $0.00 10-K · filed 2020-11-19 | ||||
| 2019-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-19 | $0.00 derived: sum of 2 quarters · filed 2020-11-19 | $0.00 derived: sum of 3 quarters · filed 2020-11-19 | $0.00 10-K · filed 2020-11-19 | |
| 2019-06-30 | $0.00 10-Q · filed 2019-08-01 | $0.00 derived: sum of 2 quarters · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | ||
| 2019-03-31 | $0.00 10-Q · filed 2019-05-02 | $0.00 10-Q · filed 2019-05-02 | |||
| 2018-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-11-19 | $0.00 derived: sum of 2 quarters · filed 2020-11-19 | $42.30M derived: sum of 3 quarters · filed 2020-11-19 | $42.33M 10-K · filed 2020-11-19 | |
| 2018-06-30 | $0.00 10-Q · filed 2019-08-01 | $42.30M derived: sum of 2 quarters · filed 2019-11-19 | $42.33M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $42.30M 10-K · filed 2019-11-19 | $42.33M 10-Q · filed 2018-05-02 | $42.33M 10-Q · filed 2019-05-02 | ||
| 2017-09-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-19 | $0.00 derived: sum of 2 quarters · filed 2019-11-19 | $0.00 derived: sum of 3 quarters · filed 2019-11-19 | $0.00 10-K · filed 2019-11-19 | |
| 2017-06-30 | $0.00 10-Q · filed 2018-08-02 | $0.00 derived: sum of 2 quarters · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-05-02 | $0.00 10-Q · filed 2018-05-02 | |||
| 2016-09-30 | $0.00 10-K · filed 2018-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |